We have previously demonstrated that administering TAC at a higher dose (1 mg/kg, i.p.)for 14 days reduces tau and Aβ proteins in the hippocampus of 3xTg-AD mice [19]. This evidence concerns the gene MAPT and Alzheimer disease.